Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer

NCT06611891 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Metastatic

Interventions

DRUG: 68Ga-DOTATOC

Sponsor

University Hospital, Grenoble